 Johan Van Hove
Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperglycinemia, Nonketotic | 9 | 2024 | 51 | 3.940 |
Why?
| | DNA, Mitochondrial | 6 | 2021 | 200 | 1.940 |
Why?
| | Mitochondrial Diseases | 7 | 2024 | 91 | 1.750 |
Why?
| | Epilepsy | 8 | 2022 | 333 | 1.740 |
Why?
| | Glycine | 5 | 2024 | 176 | 1.600 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2022 | 100 | 1.430 |
Why?
| | Cardiomyopathies | 3 | 2024 | 350 | 1.410 |
Why?
| | Mitochondrial Proteins | 5 | 2021 | 257 | 1.370 |
Why?
| | Mutation | 17 | 2024 | 3959 | 1.300 |
Why?
| | Acyl-CoA Dehydrogenases | 2 | 2024 | 12 | 1.080 |
Why?
| | Pyridoxine | 6 | 2022 | 36 | 0.990 |
Why?
| | Mitochondria | 6 | 2021 | 948 | 0.990 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.880 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 28 | 0.870 |
Why?
| | Acidosis, Lactic | 1 | 2024 | 46 | 0.850 |
Why?
| | Alagille Syndrome | 1 | 2024 | 33 | 0.840 |
Why?
| | Niacinamide | 1 | 2024 | 82 | 0.840 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 40 | 0.840 |
Why?
| | Infant | 27 | 2025 | 9482 | 0.810 |
Why?
| | Leukoencephalopathies | 2 | 2019 | 19 | 0.760 |
Why?
| | Corpus Callosum | 2 | 2019 | 71 | 0.750 |
Why?
| | Biliary Atresia | 1 | 2024 | 163 | 0.750 |
Why?
| | Lysine | 5 | 2022 | 294 | 0.700 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 93 | 0.690 |
Why?
| | Phenotype | 6 | 2024 | 3196 | 0.670 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2024 | 279 | 0.670 |
Why?
| | White Matter | 2 | 2019 | 145 | 0.670 |
Why?
| | Electron Transport Complex I | 1 | 2019 | 41 | 0.640 |
Why?
| | Diseases in Twins | 1 | 2019 | 169 | 0.600 |
Why?
| | Energy Metabolism | 3 | 2015 | 922 | 0.590 |
Why?
| | Thalamus | 1 | 2019 | 107 | 0.590 |
Why?
| | Protein Biosynthesis | 1 | 2021 | 433 | 0.590 |
Why?
| | Arginine | 2 | 2020 | 271 | 0.570 |
Why?
| | Magnetic Resonance Imaging | 10 | 2020 | 3577 | 0.560 |
Why?
| | Infant, Newborn | 15 | 2025 | 6084 | 0.530 |
Why?
| | Leigh Disease | 3 | 2015 | 21 | 0.530 |
Why?
| | Vitamin B Complex | 2 | 2015 | 44 | 0.530 |
Why?
| | Mutation, Missense | 2 | 2016 | 341 | 0.520 |
Why?
| | Glycine Decarboxylase Complex | 1 | 2016 | 5 | 0.510 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2016 | 6 | 0.510 |
Why?
| | Aminomethyltransferase | 1 | 2016 | 8 | 0.510 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.460 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.460 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2015 | 19 | 0.460 |
Why?
| | Mitochondrial Myopathies | 2 | 2023 | 9 | 0.450 |
Why?
| | Sulfurtransferases | 1 | 2013 | 10 | 0.430 |
Why?
| | Glutaredoxins | 1 | 2013 | 13 | 0.430 |
Why?
| | Spasm | 1 | 2013 | 20 | 0.420 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4295 | 0.420 |
Why?
| | Genetic Variation | 2 | 2021 | 991 | 0.410 |
Why?
| | Brain | 7 | 2024 | 2677 | 0.410 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5764 | 0.410 |
Why?
| | DNA Mutational Analysis | 8 | 2019 | 399 | 0.380 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 181 | 0.380 |
Why?
| | Channelopathies | 1 | 2011 | 5 | 0.360 |
Why?
| | Metabolic Diseases | 2 | 2010 | 108 | 0.360 |
Why?
| | Humans | 48 | 2025 | 137782 | 0.360 |
Why?
| | Amino Acids | 1 | 2015 | 497 | 0.360 |
Why?
| | Liver Diseases | 2 | 2013 | 315 | 0.350 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 81 | 0.350 |
Why?
| | Seizures | 3 | 2011 | 426 | 0.350 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.340 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 8 | 0.340 |
Why?
| | Male | 28 | 2025 | 67906 | 0.330 |
Why?
| | Neurogenesis | 1 | 2011 | 149 | 0.310 |
Why?
| | Ophthalmoplegia, Chronic Progressive External | 1 | 2009 | 3 | 0.310 |
Why?
| | Female | 28 | 2025 | 73465 | 0.310 |
Why?
| | Holocarboxylase Synthetase Deficiency | 1 | 2008 | 2 | 0.300 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 2008 | 5 | 0.300 |
Why?
| | Anticonvulsants | 2 | 2010 | 217 | 0.300 |
Why?
| | Nutrition Therapy | 1 | 2009 | 37 | 0.300 |
Why?
| | Biotin | 1 | 2008 | 28 | 0.300 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1457 | 0.290 |
Why?
| | RNA, Transfer, Glu | 1 | 2007 | 6 | 0.280 |
Why?
| | DNA Helicases | 1 | 2009 | 145 | 0.280 |
Why?
| | Proteins | 1 | 2013 | 1009 | 0.270 |
Why?
| | Vitamin B 12 | 2 | 2021 | 128 | 0.270 |
Why?
| | Enoyl-CoA Hydratase | 2 | 2025 | 12 | 0.270 |
Why?
| | Fibroblasts | 4 | 2025 | 996 | 0.260 |
Why?
| | Practice Guidelines as Topic | 2 | 2013 | 1586 | 0.260 |
Why?
| | Biomarkers | 4 | 2025 | 4154 | 0.260 |
Why?
| | Oxidative Phosphorylation | 2 | 2021 | 193 | 0.260 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2900 | 0.250 |
Why?
| | GTP Cyclohydrolase | 1 | 2006 | 9 | 0.250 |
Why?
| | Paraparesis, Spastic | 1 | 2006 | 2 | 0.250 |
Why?
| | RNA, Transfer, Asp | 1 | 2005 | 3 | 0.240 |
Why?
| | Fatal Outcome | 3 | 2013 | 303 | 0.240 |
Why?
| | Dystonia | 1 | 2006 | 25 | 0.240 |
Why?
| | Parkinsonian Disorders | 1 | 2006 | 35 | 0.240 |
Why?
| | Child | 15 | 2024 | 21989 | 0.240 |
Why?
| | Child, Preschool | 11 | 2019 | 11105 | 0.240 |
Why?
| | Tremor | 1 | 2006 | 65 | 0.240 |
Why?
| | Benzoic Acid | 1 | 2005 | 5 | 0.230 |
Why?
| | Polymers | 1 | 2009 | 490 | 0.230 |
Why?
| | Heterozygote | 3 | 2017 | 293 | 0.230 |
Why?
| | Benzoates | 1 | 2005 | 43 | 0.230 |
Why?
| | Carnitine | 1 | 2025 | 84 | 0.230 |
Why?
| | Eye | 2 | 2019 | 108 | 0.220 |
Why?
| | Amino Acid Sequence | 5 | 2015 | 2139 | 0.220 |
Why?
| | Brain Diseases | 3 | 2015 | 141 | 0.210 |
Why?
| | Hydrocephalus | 2 | 2024 | 106 | 0.210 |
Why?
| | Glucose | 1 | 2009 | 1020 | 0.210 |
Why?
| | Dietary Supplements | 2 | 2020 | 561 | 0.210 |
Why?
| | Genotype | 3 | 2019 | 1917 | 0.210 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2003 | 17 | 0.200 |
Why?
| | Drug Combinations | 1 | 2024 | 343 | 0.200 |
Why?
| | Pedigree | 3 | 2019 | 514 | 0.190 |
Why?
| | Point Mutation | 2 | 2017 | 235 | 0.180 |
Why?
| | Animals, Newborn | 1 | 2024 | 844 | 0.180 |
Why?
| | 2-Aminoadipic Acid | 2 | 2019 | 8 | 0.180 |
Why?
| | Echocardiography | 1 | 2024 | 644 | 0.180 |
Why?
| | Methionine | 1 | 2021 | 160 | 0.170 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2020 | 9 | 0.170 |
Why?
| | External Capsule | 1 | 2019 | 2 | 0.160 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 14 | 0.160 |
Why?
| | NADH Dehydrogenase | 1 | 2019 | 19 | 0.160 |
Why?
| | Adolescent | 10 | 2020 | 21574 | 0.160 |
Why?
| | Porencephaly | 1 | 2019 | 6 | 0.160 |
Why?
| | Collagen Type IV | 1 | 2019 | 28 | 0.150 |
Why?
| | Twins, Monozygotic | 1 | 2019 | 203 | 0.150 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 2 | 2021 | 24 | 0.150 |
Why?
| | Spectrum Analysis | 1 | 2019 | 91 | 0.150 |
Why?
| | Proteomics | 2 | 2024 | 1111 | 0.150 |
Why?
| | Lactic Acid | 1 | 2019 | 305 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 189 | 0.140 |
Why?
| | Cell Respiration | 2 | 2015 | 103 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2019 | 611 | 0.130 |
Why?
| | Acyl-CoA Dehydrogenase | 2 | 2009 | 8 | 0.130 |
Why?
| | Liver | 3 | 2015 | 1943 | 0.130 |
Why?
| | Dihydrolipoamide Dehydrogenase | 1 | 2016 | 7 | 0.130 |
Why?
| | Cataract | 1 | 2019 | 213 | 0.130 |
Why?
| | Gene Expression | 2 | 2015 | 1502 | 0.120 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 31 | 0.120 |
Why?
| | Lysosomal Storage Diseases | 1 | 2015 | 5 | 0.120 |
Why?
| | Introns | 1 | 2016 | 258 | 0.120 |
Why?
| | COS Cells | 1 | 2015 | 188 | 0.120 |
Why?
| | Diet Therapy | 1 | 2015 | 37 | 0.120 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 30 | 0.120 |
Why?
| | Dyskinesias | 1 | 2015 | 19 | 0.120 |
Why?
| | Exons | 1 | 2016 | 355 | 0.120 |
Why?
| | Prognosis | 2 | 2015 | 4039 | 0.110 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 92 | 0.110 |
Why?
| | Electron Transport | 1 | 2015 | 115 | 0.110 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 374 | 0.110 |
Why?
| | Base Sequence | 2 | 2010 | 2181 | 0.110 |
Why?
| | Demyelinating Diseases | 1 | 2015 | 85 | 0.110 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.110 |
Why?
| | Cell Line | 1 | 2019 | 2847 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 326 | 0.110 |
Why?
| | Genes, X-Linked | 1 | 2013 | 18 | 0.100 |
Why?
| | Host Cell Factor C1 | 1 | 2013 | 15 | 0.100 |
Why?
| | Treatment Outcome | 6 | 2023 | 10837 | 0.100 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 27 | 0.100 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2013 | 24 | 0.100 |
Why?
| | Cytochrome-c Oxidase Deficiency | 1 | 2013 | 4 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 3 | 2013 | 2427 | 0.100 |
Why?
| | Atrophy | 1 | 2013 | 184 | 0.100 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 26 | 0.100 |
Why?
| | Stilbenes | 1 | 2013 | 35 | 0.100 |
Why?
| | Genetic Testing | 1 | 2016 | 462 | 0.100 |
Why?
| | Alleles | 1 | 2016 | 892 | 0.100 |
Why?
| | Sequence Alignment | 2 | 2015 | 343 | 0.100 |
Why?
| | DNA | 1 | 2019 | 1459 | 0.090 |
Why?
| | Liver Transplantation | 1 | 2020 | 871 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1067 | 0.090 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 23 | 0.090 |
Why?
| | Genetic Association Studies | 2 | 2010 | 377 | 0.090 |
Why?
| | Vitamin B 6 | 1 | 2011 | 10 | 0.090 |
Why?
| | Time | 1 | 2011 | 83 | 0.090 |
Why?
| | Quality of Life | 1 | 2023 | 2894 | 0.090 |
Why?
| | Cystathionine beta-Synthase | 1 | 2011 | 71 | 0.090 |
Why?
| | Age of Onset | 3 | 2013 | 520 | 0.090 |
Why?
| | Homocystinuria | 1 | 2011 | 71 | 0.080 |
Why?
| | Diffuse Cerebral Sclerosis of Schilder | 1 | 2010 | 4 | 0.080 |
Why?
| | Sirtuin 3 | 1 | 2011 | 61 | 0.080 |
Why?
| | Chemokines | 1 | 2011 | 228 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2019 | 15682 | 0.080 |
Why?
| | Adult | 7 | 2021 | 38023 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2041 | 0.080 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2010 | 44 | 0.080 |
Why?
| | Animals | 4 | 2024 | 36951 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 201 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 1002 | 0.080 |
Why?
| | Mice | 3 | 2024 | 17794 | 0.080 |
Why?
| | Biogenic Monoamines | 1 | 2009 | 16 | 0.080 |
Why?
| | Structure-Activity Relationship | 1 | 2010 | 570 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 521 | 0.080 |
Why?
| | Leucovorin | 1 | 2009 | 81 | 0.080 |
Why?
| | Neonatal Screening | 1 | 2010 | 169 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2009 | 183 | 0.070 |
Why?
| | Nervous System Diseases | 1 | 2011 | 266 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2009 | 239 | 0.070 |
Why?
| | Pregnancy Complications | 2 | 2011 | 527 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 322 | 0.070 |
Why?
| | Fatty Liver | 1 | 2011 | 243 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2010 | 264 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5478 | 0.070 |
Why?
| | Protein Conformation | 1 | 2010 | 934 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1483 | 0.070 |
Why?
| | Reflex, Abnormal | 1 | 2006 | 7 | 0.060 |
Why?
| | Phenylalanine | 1 | 2006 | 68 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2836 | 0.060 |
Why?
| | Tendinopathy | 1 | 2006 | 27 | 0.060 |
Why?
| | Diet | 3 | 2012 | 1279 | 0.060 |
Why?
| | Models, Molecular | 1 | 2010 | 1570 | 0.060 |
Why?
| | Sodium Benzoate | 1 | 2005 | 5 | 0.060 |
Why?
| | Amino Acid Oxidoreductases | 1 | 2005 | 19 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2013 | 4193 | 0.060 |
Why?
| | Kinetics | 1 | 2008 | 1670 | 0.060 |
Why?
| | Transferases | 1 | 2005 | 33 | 0.060 |
Why?
| | Psychomotor Disorders | 1 | 2004 | 13 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 358 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2011 | 5136 | 0.060 |
Why?
| | Consensus | 2 | 2020 | 683 | 0.060 |
Why?
| | Multienzyme Complexes | 1 | 2005 | 68 | 0.060 |
Why?
| | Motor Skills Disorders | 1 | 2005 | 28 | 0.060 |
Why?
| | Physicians | 1 | 2013 | 914 | 0.060 |
Why?
| | Dried Blood Spot Testing | 1 | 2025 | 104 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1313 | 0.060 |
Why?
| | Young Adult | 2 | 2011 | 13240 | 0.050 |
Why?
| | Merozoite Surface Protein 1 | 1 | 2023 | 4 | 0.050 |
Why?
| | Stereoisomerism | 1 | 2003 | 96 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1062 | 0.050 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 256 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 18 | 0.050 |
Why?
| | Biopsy | 1 | 2005 | 1130 | 0.050 |
Why?
| | Circadian Rhythm | 1 | 2006 | 468 | 0.050 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 41 | 0.050 |
Why?
| | Lower Extremity | 1 | 2006 | 434 | 0.050 |
Why?
| | Homocysteine | 1 | 2021 | 156 | 0.040 |
Why?
| | Pipecolic Acids | 2 | 2012 | 26 | 0.040 |
Why?
| | Fatigue | 1 | 2023 | 329 | 0.040 |
Why?
| | Pregnancy | 2 | 2011 | 6771 | 0.040 |
Why?
| | Cognition | 2 | 2022 | 1157 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2005 | 771 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 242 | 0.040 |
Why?
| | Thymidine | 1 | 2020 | 60 | 0.040 |
Why?
| | Colorado | 1 | 2010 | 4576 | 0.040 |
Why?
| | International Cooperation | 1 | 2020 | 198 | 0.040 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 27 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2010 | 1724 | 0.040 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 128 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1997 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1783 | 0.030 |
Why?
| | Age Factors | 1 | 2005 | 3305 | 0.030 |
Why?
| | Aminoacylation | 1 | 2015 | 14 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 622 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 138 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6834 | 0.030 |
Why?
| | Exome | 1 | 2015 | 231 | 0.030 |
Why?
| | Neuroglia | 1 | 2015 | 173 | 0.030 |
Why?
| | Citrate (si)-Synthase | 1 | 2013 | 60 | 0.030 |
Why?
| | Delphi Technique | 1 | 2014 | 281 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2013 | 60 | 0.030 |
Why?
| | Myelin Sheath | 1 | 2015 | 167 | 0.030 |
Why?
| | Middle Aged | 2 | 2023 | 33554 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 327 | 0.020 |
Why?
| | North America | 1 | 2013 | 313 | 0.020 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 23 | 0.020 |
Why?
| | Betaine | 1 | 2011 | 73 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 622 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 58 | 0.020 |
Why?
| | Northwestern United States | 1 | 2010 | 55 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 730 | 0.020 |
Why?
| | Southwestern United States | 1 | 2010 | 91 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 119 | 0.020 |
Why?
| | Patient Care Management | 1 | 2010 | 57 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 740 | 0.020 |
Why?
| | DNA Polymerase gamma | 1 | 2010 | 8 | 0.020 |
Why?
| | Public Health Practice | 1 | 2010 | 70 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 248 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1303 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2013 | 427 | 0.020 |
Why?
| | Aged | 1 | 2009 | 24001 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 372 | 0.020 |
Why?
| | Family Health | 1 | 2010 | 196 | 0.020 |
Why?
| | Information Dissemination | 1 | 2010 | 218 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2010 | 452 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2010 | 209 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 518 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2010 | 739 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2224 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 778 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1946 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 849 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 532 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1242 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2167 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2834 | 0.010 |
Why?
| | Myoclonic Epilepsy, Juvenile | 1 | 2004 | 1 | 0.010 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2004 | 12 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2860 | 0.010 |
Why?
| | Nystagmus, Pathologic | 1 | 2004 | 13 | 0.010 |
Why?
| | Apnea | 1 | 2004 | 22 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2607 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 3018 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3290 | 0.010 |
Why?
| | Health Surveys | 1 | 2004 | 514 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1325 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2004 | 645 | 0.010 |
Why?
| | Sex Factors | 1 | 2004 | 2077 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 2760 | 0.010 |
Why?
| | Registries | 1 | 2004 | 2041 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2004 | 5793 | 0.010 |
Why?
|
|
Van Hove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|